In the present report, we show that a reduced CUL5 gene expression or CUL5 deletion is associated with significantly impaired overall survival in ccRCC patients and with more rapid tumor progression, respectively. This evidence concerns the gene CUL5 and nonpapillary renal cell carcinoma.